Thought I'd start a new thread on stem-cell therapy milestones. For me the regulatory landscape made a significant shift with COVID-19 stem-cell treatments being included in FDA trials (see other threads to gauge how the FDA is engaging properly trialed stem-cell therapies). To me this all changes the wider environment for acceptance of stem-cell treatments including OCC's ATI treatment, the obvious gold-star treatment for degenerative tendons. Presumably many of you will be interested in general stem-cell therapies on a wider front. Another recent milestone:
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)